Medication noncompliance in chronic kidney disease

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 354-362

  Moreira, Leonardo B ^a   Fernandes, Paula Frassinetti Castelo Branco Camurça ^a,b   Mota, Rosa S ^a   Monte, Francisca S ^a   Galvao, Rita I M ^a   Sousa, Daniel F ^a   Martins, Alice M C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Chronic kidney failure; Drug utilization; Patient compliance

Indexed keywords

CAPTOPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; PREDNISONE; ANTIHYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DRUG INFORMATION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREVALENCE; RISK FACTOR; SELF REPORT; CHRONIC DISEASE; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT EDUCATION; SOCIOECONOMICS; TREATMENT REFUSAL;

ADULT; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; SOCIOECONOMIC FACTORS; TREATMENT REFUSAL;

EID: 52049099215     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-S266.
2. Romão JE Jr. Doença renal crônica: definição, epidemiologia e classificação. J Bras Nefrol. 2004;26(suppl 1):1-3.
3. American Diabetes Association. Clinical practice recommendations. Diabetes Care. 2006;29(suppl 1):S4-S85.
4. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
5. Lee JY, Kusek JW, Greene, PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996;9:719-725.
6. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408-1412.
7. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period. Diabetes Care. 2003;26:3054-3060.
8. Strelec MA, Pierin AM, Mion D Jr. The influence of patient's consciousness regarding high blood pressure and patient's attitude in face of disease controlling medicine intake. Arq Bras Cardiol. 2003;81:349-354.
9. Kilbourne AM, Good CB, Sereika SM, Justice AC, Fine MJ. Algorithm for assessing patients' adherence to oral hypoglycemic medication. Am J Health Syst Pharm. 2005;62:198-204.
10. Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation. 2000;70:711-716.
11. Cramer JA. Effect of partial compliance on cardiovascular medication effectiveness. Heart. 2002;88:203-206.
12. Rybacki JJ. Improving cardiovascular health in post-menopausal women by addressing medication adherence issues. J Am Pharm Assoc. 2002;42:63-71.
13. Piccoli GB, Soragna G, Mezza E, et al. Lost to follow-up: the bottleneck of early referral to renal units? Med Sci Monit. 2003;9:CR493-CR499.
14. Christensen AJ. Patient-by-treatment context interaction in chronic disease: a conceptual framework for the study of patient adherence. Psychosom Med. 2000;62:435-443.
15. Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant. 2001;16(suppl 7):20-24.
16. Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care. 2003;9:155-171.
17. Vasquez EM, Tanzi M, Benedetti E, Pollak R. Medication compliance after kidney transplantation. Am J Health Syst Pharm. 2003;60:266-269.
18. Silva T, Schenkel EP, Mengue SS. Patient knowledge about drugs prescribed in a teaching hospital. Cad Saude Publica. 2000;16:449-455.
19. Frassinetti Fernandes P, Ellis PA, Roderick PJ, Cairns HS, Hicks JA, Cameron JS. Causes of end-stage renal failure in black patients starting renal replacement therapy. Am J Kidney Dis. 2000;36:301-309.
20. Lee JY, Greene PG, Douglas M, et al. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials. 1996;16:34S-39S.
21. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003.
22. Gordis L. Conceptual and methodologic problems in measuring patient compliance. In: Haynes RB, Taylor DW, Sackett DL, ed. Compliance in Health Care. Baltimore, MA: Johns Hopkins University; 1979:23-62.
23. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132:926-930.
24. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2005;CD000011.
25. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288:2880-2883.
26. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27:2800-2805.
27. Andrade JP, Vilas-Boas F, Chagas H, Andrade M. Epidemiological aspects of adherence to the treatment of hypertension. Arq Bras Cardiol. 2002;79:380-384.
28. Mion D Jr, Ortega KC. Should we spend less or control a greater percentage of hypertensive patients? Sao Paulo Med J. 2002;120:99.
29. Hernandez-Ronquillo L, Tellez-Zenteno JF, Garduno-Espinosa J, Gonzalez-Acevez E. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex. 2003;45:191-197.
30. Busnello RG, Melchior R, Faccin C, et al. Characteristics associated with the dropout of hypertensive patients followed up in an outpatient referral clinic. Arq Bras Cardiol. 2001;76:352-354.
31. Farley D. FDA's Rx for better medication information. FDA Consum. 1995;29:5-10.
32. Burge S, White D, Bajorek E, et al. Correlates of medication knowledge and adherence: findings from the residency research network of South Texas. Fam Med. 2005;37:712-718.
33. Friedman EA. Must we treat noncompliant ESRD patients? Semin Dial. 2001;14:23-27.
34. Tellez A. Prevention and patient's compliance: two key factors to deal with non communicable chronic diseases. Rev Med Chil. 2004;132:1453-1455.
35. Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158:29-35.
36. de Lima MB, Mello DA, Morais AP, da Silva WC. Non-adherence to tuberculosis treatment: a study on perceptions and knowledge of the disease and evaluation of health services from the patient perspective. Cad Saude Publica. 2001;17:877-885.
37. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;CD004804.